MCC 18613, Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults

Grant

Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • Contributor

  • Elizabeth Alva   Investigator  
  • Emily Johnston   Investigator  
  • Jamie Aye   Investigator  
  • Kimberly Whelan M.D.   Principal Investigator